Viewing nowPurosin Tablet 250 mg (Ciprofloxacin Hydrochloride Monohydrate)
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

MFDS item code 199102393 · Notified 1991.08.26 · Insurance code 661901880
Treatment of genitourinary infections, respiratory and ear, nose, and throat infections, and other infections (e.g., skin and eye infections)
This medication is effective against various bacterial infections such as E. coli, Shigella, and Salmonella. It is used to treat respiratory infections excluding acute bronchitis and community-acquired pneumonia, as well as infections of the ear, nose, and throat, bacterial prostatitis, acute pyelonephritis, and other urinary tract infections. Additionally, it is used to treat bacterial infections in various locations including gastrointestinal infections, infections of the bile ducts, skin and soft tissue infections, bone and joint infections, and gynecological infections. As a fluoroquinolone antibiotic, it has a potential for serious adverse reactions and should only be used when no alternative treatment is available for certain conditions. Overall, it is used to improve a wide range of bacterial infections.
○ Usually, adults take 250 ~ 500 mg of ciprofloxacin orally twice daily between meals. For severe complicated infections, the dose of this medication may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually continued for 5 ~ 10 days and for at least 3 days after symptoms disappear. ○ Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance may be calculated using the following equations. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, the dose per administration may be increased to 750 mg even in patients with severe renal impairment; however, the patient's condition should be monitored carefully after administration. Adjust the dose appropriately according to symptoms.
This medication may cause serious side effects such as tendonitis, tendon rupture, peripheral neuropathy, and central nervous system abnormalities. If such symptoms occur, the patient should immediately discontinue use and consult a physician. Patients with myasthenia gravis should not take this medication as it may worsen symptoms. Pregnant women, nursing mothers, children under 18 years old, and patients with epilepsy should not take this medication. The risk of side effects may increase when taken with certain medications, so it is important to inform the physician of any other medications being taken. Elderly patients or those with impaired kidney function may be at a higher risk for side effects, and dosages and administration intervals should be adjusted as necessary. During the course of treatment, patients should avoid strong sunlight or artificial ultraviolet exposure and should discontinue use immediately if symptoms of photosensitivity appear. Caution is advised when driving or operating machinery, and it is best to avoid consuming alcohol while taking this medication. Diabetic patients requiring blood sugar control should closely monitor for changes in blood glucose levels. If diarrhea or severe abdominal pain occurs during treatment, there may be a risk of pseudomembranous colitis, and immediate consultation with medical personnel is necessary. In case of overdose, renal function should be closely monitored, and appropriate emergency treatment should be provided as necessary. The safety of this medication has not been established for children and adolescents in the growth phase.
Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effects, worsening of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombophlebitis, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reaction, allergic edema, angioedema, anaphylactic reaction, anaphylactoid shock, serum sickness-like reaction, decreased appetite, reduced food intake, increased alkaline phosphatase in the blood, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, sensory abnormalities, sensory decreased perception, loss of taste, tremor, convulsions, dizziness, mental confusion, seizures, drowsiness, migraine, coordination disorder, olfactory disorders, anosmia, hypersensitivity, increased intracranial pressure, ataxia, peripheral neuropathy, polyneuropathy, visual impairment, color vision deficiency, diplopia, tinnitus, hearing loss, transient hearing loss, hearing damage, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, membrane colitis, colitis with bloody stools, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, liver dysfunction, jaundice, hepatitis, cholestatic jaundice, liver necrosis, rash, pruritus, urticaria, photosensitivity, vesicles, petechial hemorrhage, erythema multiforme, drug reaction with eosinophilia and systemic symptoms (DRESS), toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tone and cramps, joint edema, muscle weakness, partial or full tendon rupture, renal impairment, acute renal failure, hematuria, crystalluria, interstitial nephritis, vulvovaginal candidiasis, unexplained pain, discomfort, fever, asthenia, edema, sweating, gait disturbance, maculopapular rash, purpuric rash, injection site rash, injection site pruritus, injection site urticaria, aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, seizures, increased intracranial pressure, dizziness, tremors, depression, psychotic reactions, suicidal thoughts, suicide attempt, self-harming behavior, membrane colitis, photosensitivity reactions, sensory abnormalities, diminished perception, perceptual disturbances, convulsions, cardiac arrest, neuroleptic seizure, status epilepticus, respiratory failure, hypotension, dyspnea, chest tightness, rhabdomyolysis, muscle weakness, interstitial pneumonia, visual impairment, acute respiratory distress, palpitations, abdominal or limb edema
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering, and it should be kept at room temperature away from direct sunlight. Proper storage will help maintain the medication's effectiveness and prevent degradation.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 500 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCiprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Youngpoong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291.5mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Ciprofloxacin Hydrochloride
Prescription medication
Dongkwang Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 291mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride 582mg
Tablet · Prescription medication
Il Dong Pharmaceutical Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Korea United Pharm, Inc.
Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.

Ciprofloxacin Hydrochloride Hydrate 291mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.